Citations to this article


To evaluate the role of tumor necrosis factor (TNF alpha) in bone loss resulting from estrogen deficiency, the effects of ovariectomy were explored in six-month-old transgenic mice expressing high blood levels of a soluble TNF receptor type I (sTNFR1)-FcIgG3 fusion protein, which neutralizes TNF alpha, and in their nontransgenic littermates used as controls. These transgenic mice were identical to control mice in bone mass (evaluated by bone mineral density and content) and strength. 12 weeks after ovariectomy, the decrease in bone mass and increase in osteocalcin (marker of bone turnover) found in control mice were not observed in transgenic mice, which were not different from sham-operated mice, transgenic or not. This observation suggests a critical role for TNF alpha in the pathogenesis of bone loss induced by estrogen deficiency, a common cause of morbidity in postmenopausal women.


P Ammann, R Rizzoli, J P Bonjour, S Bourrin, J M Meyer, P Vassalli, I Garcia


Total citations by year in Crossref

Year: 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 Total
Citations: 5 1 7 6 7 5 2 5 7 9 13 4 3 5 7 9 11 9 3 118
Citation information

Citations to this article in Crossref (118)

Title and authors Publication Year
Siglec-15 is a potential therapeutic target for postmenopausal osteoporosis
Y Kameda, M Takahata, S Mikuni, T Shimizu, H Hamano, T Angata, S Hatakeyama, M Kinjo, N Iwasaki
Bone 2015
Adalimumab Therapy Has a Beneficial Effect on Bone Metabolism in Patients with Crohn’s Disease
SG Veerappan, M Healy, BJ Walsh, CA O’Morain, JS Daly, BM Ryan
Digestive Diseases and Sciences 2015
Pros and cons of fatty acids in bone biology
F Wauquier, L Léotoing, C Philippe, M Spilmont, V Coxam, Y Wittrant
Progress in Lipid Research 2015
Childhood obesity, bone development, and cardiometabolic risk factors
NK Pollock
Molecular and Cellular Endocrinology 2015
A Bone Anabolic Effect of RANKL in a Murine Model of Osteoporosis Mediated Through FoxP3 + CD8 T Cells: LOW DOSE RANKL AMELIORATES OSTEOPOROSIS
ZS Buchwald, C Yang, S Nellore, EV Shashkova, JL Davis, A Cline, J Ko, DV Novack, R DiPaolo, R Aurora
Journal of Bone and Mineral Research 2015
Estrogen-responsive genes for environmental studies
R Kiyama, Y Zhu, K Kawaguchi, N Iitake, Y Wada-Kiyama, S Dong
Environmental Technology & Innovation 2014
Advances in Osteoimmunology: Pathophysiologic Concepts and Treatment Opportunities
M Rauner, W Sipos, S Thiele, P Pietschmann
International Archives of Allergy and Immunology 2013
Catechins and osteoporosis
UN Das
Nutrition 2013
Biologic therapies and systemic bone loss in Rheumatoid Arthritis
T Dimitroulas, SN Nikas, P Trontzas, GD Kitas
Autoimmunity Reviews 2013
LF Bonewald
Osteoporosis International 2013
Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism
MT Drake, S Khosla
Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism 2013
Influence of sex steroids on inflammation and bone metabolism
HJ Shiau, ME Aichelmann-Reidy, MA Reynolds
Periodontology 2000 2013
The limited effects of anti-tumor necrosis factor blockade on bone health in patients with rheumatoid arthritis under the use of glucocorticoid
T Okano, T Koike, M Tada, Y Sugioka, K Mamoto, S Wakitani, H Nakamura
Journal of Bone and Mineral Metabolism 2013
Role of T cells in ovariectomy induced bone loss-revisited
R Pacifici
Journal of Bone and Mineral Research 2012
Targeting tumor necrosis factor alpha (TNF-α) in diabetic rats could approve avenues for an efficient strategy for diabetic therapy
KK Abdul-Aziz, MJ Tuorkey
Diabetes & Metabolic Syndrome: Clinical Research & Reviews 2012
Lokale und systemische Knocheneffekte bei rheumatoider Arthritis
M Rauner, LC Hofbauer, M Aringer
Zeitschrift für Rheumatologie 2012
The effect of TNFα secreted from macrophages activated by titanium particles on osteogenic activity regulated by WNT/BMP signaling in osteoprogenitor cells
SS Lee, AR Sharma, BS Choi, JS Jung, JD Chang, S Park, EA Salvati, EP Purdue, DK Song, JS Nam
Biomaterials 2012
Infliximab improves bone metabolism and bone mineral density in rheumatoid arthritis and ankylosing spondylitis: a prospective 2-year study
G Dischereit, IH Tarner, U Müller-Ladner, U Lange
Clinical Rheumatology 2012
Effects of Chrysanthemum indicum L. Extract on the Function of Osteoblastic MC3T3-E1 Cells under Oxidative Stress Induced by Hydrogen PeroxideJee
JH Yun, ES Hwang, GH Kim
Korean Journal of Food Science and Technology 2012
The effects of Labisia pumila var. alata on bone markers and bone calcium in a rat model of post-menopausal osteoporosis
AN Shuid, LL Ping, N Muhammad, N Mohamed, IN Soelaiman
Journal of Ethnopharmacology 2011
IL-33 is expressed in human osteoblasts, but has no direct effect on bone remodeling
S Saidi, F Bouri, P Lencel, L Duplomb, M Baud’huin, S Delplace, D Leterme, F Miellot, D Heymann, P Hardouin, G Palmer, D Magne
Cytokine 2011
Distinct impacts of syndesmophyte formation on male and female patients with ankylosing spondylitis : Inflammatory factors and bone metabolism markers in AS
International Journal of Rheumatic Diseases 2011
Anti-TNFα therapy and prevention of bone loss in rheumatoid arthritis
C Roux
IBMS BoneKEy 2011
BF Boyce, L Xing, EM Schwarz
Osteoimmunology 2011
Inflammaging: The driving force in osteoporosis?
P Lencel, D Magne
Medical Hypotheses 2011